By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Moleculin Biotech 

2575 West Bellfort
Suite 333
Houston  Texas  77054  U.S.A.
Phone: 713-300-5160 Fax: n/a


SEARCH JOBS

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center, the world’s largest cancer research facility headquartered within the world’s largest medical center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

YEAR FOUNDED:

2015

LEADERSHIP:

Founder, Chairman, CEO, and Business Advisory Board Member: Walter V. Klemp

President and COO: Donald Picker

CMO: Robert Shepard, MD, FACP

Executive VP and CFO: Jonathan P. Foster

Business Advisory Board Member: Lori H. Bisson

TECHNOLOGY:

Please click here for Moleculin Biotech's technology.


Key Statistics


Email: info@moleculin.com
Ownership: Public

Web Site: Moleculin Biotech
Employees:
Symbol: MBRX
 



Industry
Biotechnology






Company News
Moleculin Biotech (MBRX) Reports Financial Results For The Third Quarter Ended September 30, 2016 11/21/2016 11:37:30 AM
Moleculin Announces Positive FDA Guidance Regarding Annamycin IND 11/17/2016 10:14:02 AM
Moleculin Announces Advancement Of Preclinical Testing For Brain Tumor Drug WP1122 10/26/2016 8:46:38 AM
Moleculin Announces Accelerated Plan for Clinical Trial Drug Production 10/7/2016 12:05:38 PM
Moleculin To Present At OktoberINVESTfest 9/23/2016 1:35:46 PM
Moleculin Announces Participation At The 18th Annual Rodman & Renshaw Global Investment Conference In New York City September 11-13th, 2016 9/7/2016 11:56:44 AM
Moleculin Appoints New Chief Financial Officer 8/22/2016 8:26:49 AM
Moleculin Announces Data On WP1122 Presented At The 28th Annual International Carbohydrate Symposium 7/28/2016 2:13:12 PM
Moleculin Announces Successful Engineering Run For Production Of Annamycin 7/19/2016 4:26:00 PM
Moleculin Release: Annamycin: A New Hope For AML Patients 6/6/2016 11:59:11 AM
12
//-->